Trial of a Virtual Exercise-based Rehabilitation Program to Treat Persistent Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Sponsored by University Health Network, Toronto
About this trial
Last updated 2 months ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 2 months ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* diagnosed with any type of cancer
* received chemotherapy treatment as part of curative-intent therapy (no minimum dose)
* >6 months following chemotherapy completion with no current plans for further chemotherapy
* report Grade 1 or higher on the numbness and tingling severity item of the Common Terminology Criteria for Adverse Events (CTCAE) v 5.0
* neuropathic pain 3 or higher on the Neuropathic Pain 4 (DN4) (interview)
* capable of ambulation and transfers (with or without gait/transfer aid) (ECOG score 0-2)
* are able to communicate sufficiently in English to complete intervention, questionnaires, and consent
* have access to and able to operate videoconferencing
Exclusion Criteria
* currently meeting all recommendations from the physical activity guidelines for cancer survivors
* have any neurological conditions influencing cognition (i.e. dementia, Alzheimer's) and preventing safe or appropriate engagement with exercise recommendation
* have neuropathy that pre-existed chemotherapy receipt (i.e. diabetic neuropathy)
* currently enrolled in other rehabilitation or exercise-based interventions
